“The ADHD Explosion: Clinical Realities and Policy Implications” Book Talk, Hosted by The Center for Child and Youth Policy at UC Berkeley Steve Hinshaw & Richard Scheffler Monday, March 10 4:30 p.m. All presentations will be at the Men’s Faculty Club, UC Berkeley Berkeley, CA 94720 (map) (510) 540-5678 Other events in this series: “Using Predictive […]
Stephen Hinshaw will give a talk on Feb 14 at: Teaching Self-Aware Minds: Using Brain Science to Boost Social and Emotional Skills February 13-15, 2014 At the Fairmont San Francisco Hotel in San Francisco, CA
Richard Scheffler (2008 Awardee) was quoted in “The Selling of Attention Deficit Disorder” which appeared in the New York Times, December 14, 2013.
Authors of one of the most influential studies that first trumpeted the effectiveness of ADHD medications in the 1990s say they worry the results over-sold the benefits of using the drugs alone, without other forms of therapy.
Twenty years ago, more than a dozen leaders in child psychiatry received $11 million from the NIMH to study an important question facing families with children with ADHD: Is the best long-term treatment medication, behavioral therapy or both?
After more than 50 years leading the fight to legitimize attention deficit hyperactivity disorder, Keith Conners could be celebrating.
Between the fall of 2011 and the spring of 2012, people across the United States suddenly found themselves unable to get their hands on A.D.H.D. medication.
As a young mother, Robin Richeson was overwhelmed by her son Aaron’s boundless energy. Richeson chalked up his behavior, which included climbing tall trees, running away and an inability to focus in school to boys being boys.
As the ranks of kids diagnosed with ADHD in this country continue to swell—to 12% of school-age children and as many as 20% of teenage boys, according to the CDC’s latest count—it becomes more and more urgent to look at what forces might be driving this phenomenon. The new CDC survey, in addition to measuring […]
